Drugs / WL8713
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02193139 | Dec 2013 → Jun 2014 | isolated hyperchlorhidrosis | Watson Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WL8713 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02193139 ↗ |
| Modality | Other / unclassified | “The anticholinergic agent being studied is designated WL8713.” NCT02193139 ↗ |